Nektar Therapeutics (MEX:NKTR)
MXN 51.11 0 (0%) Market Cap: 3.81 Bil Enterprise Value: 1.05 Bil PE Ratio: 0 PB Ratio: 3.85 GF Score: 53/100

Nektar Therapeutics Annual Shareholders Meeting Transcript

Jun 17, 2020 / 09:00PM GMT
Release Date Price: MXN412.44
Operator

Welcome to the 2020 Annual Meeting for Nektar Therapeutics. Our host for today's call is Mark Wilson, Senior Vice President and General Counsel. (Operator Instructions)

I will now turn the call over to your host, Mr. Wilson, you may begin, sir.

Mark A. Wilson
Nektar Therapeutics - Senior VP, General Counsel & Secretary

Thank you. I would like to welcome everyone to the Nektar Therapeutics' 2020 Annual Meeting of Stockholders. It is my pleasure to host the 2020 Annual Meeting, and I will serve as Chairman and Secretary of the meeting. We are excited to be hosting our first virtual meeting, which allows our stockholders to safely participate in our annual meeting.

As in past years, we will conduct the business portion of our meeting first and answer questions at the end of the meeting.

Before we begin, I would like to introduce the members of our Board of Directors who are with us today: Rob Chess, the Chairman of the Board; Jeff Ajer, Myriam Curet; Karin Eastham; R. Scott Greer; Lutz Lingnau; Howard Robin, who is also our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot